| Paul Thomas Lui, MD | |
|
2121 N Beverly Ave, Ste 105, Tucson, AZ 85712-2154 | |
| (520) 327-6265 | |
| (520) 327-9300 |
| Full Name | Paul Thomas Lui |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 28 Years |
| Location | 2121 N Beverly Ave, Tucson, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114923687 | NPI | - | NPPES |
| 1Z6345 | Other | AZ | HEALTH NET INSURANCE |
| 69728701 | Medicaid | AZ | |
| AZ0714210 | Other | AZ | BCBS OF ARIZONA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 30151 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tucson Central Dialysis (dva) | Tucson, AZ | Dialysis facility |
| Safford Dialysis (fmc) | Safford, AZ | Dialysis facility |
| Desert Dialysis Center (dci) | Tucson, AZ | Dialysis facility |
| Tucson East Dialysis (dva) | Tucson, AZ | Dialysis facility |
| Tucson Medical Center | Tucson, AZ | Hospital |
| Northern Cochise Community Hospital, Inc. | Willcox, AZ | Hospital |
| St Joseph's Hospital | Tucson, AZ | Hospital |
| Benson Hospital | Benson, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southwest Kidney Institute Plc | 8224930987 | 81 |
News Archive
Ever since discovering a decade ago that a gene altered in lung cancer regulated an enzyme used in therapies against diabetes, Reuben Shaw has wondered if drugs originally designed to treat metabolic diseases could also work against cancer.
Cell Signaling Technology, Inc. of Danvers, MA announced today a joint commercialization partnership with Astellas Pharma, Inc. of Tokyo, Japan focused on the delivery of personalized cancer therapeutics and diagnostics.
In other Medicaid news, Florida officials are trying to change the "Medically Needy" program and the Connecticut House passes a budget that would cut $50 million from Medicaid programs.
In RISING PLAGUE: THE GLOBAL THREAT FROM DEADLY BACTERIA AND OUR DWINDLING ARSENAL TO FIGHT THEM (Prometheus Books, $26), Dr. Brad Spellberg-an infectious diseases specialist and member of a national task force charged with attacking antibiotic resistant infections-tells the story of this potentially grave public health crisis.
› Verified 2 days ago
| Entity Name | Southwest Kidney Institute Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659316008 PECOS PAC ID: 8224930987 Enrollment ID: O20040211001069 |
News Archive
Ever since discovering a decade ago that a gene altered in lung cancer regulated an enzyme used in therapies against diabetes, Reuben Shaw has wondered if drugs originally designed to treat metabolic diseases could also work against cancer.
Cell Signaling Technology, Inc. of Danvers, MA announced today a joint commercialization partnership with Astellas Pharma, Inc. of Tokyo, Japan focused on the delivery of personalized cancer therapeutics and diagnostics.
In other Medicaid news, Florida officials are trying to change the "Medically Needy" program and the Connecticut House passes a budget that would cut $50 million from Medicaid programs.
In RISING PLAGUE: THE GLOBAL THREAT FROM DEADLY BACTERIA AND OUR DWINDLING ARSENAL TO FIGHT THEM (Prometheus Books, $26), Dr. Brad Spellberg-an infectious diseases specialist and member of a national task force charged with attacking antibiotic resistant infections-tells the story of this potentially grave public health crisis.
› Verified 2 days ago
| Entity Name | Southwest Kidney Institute Scottsdale Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902231012 PECOS PAC ID: 3577798313 Enrollment ID: O20131101000457 |
News Archive
Ever since discovering a decade ago that a gene altered in lung cancer regulated an enzyme used in therapies against diabetes, Reuben Shaw has wondered if drugs originally designed to treat metabolic diseases could also work against cancer.
Cell Signaling Technology, Inc. of Danvers, MA announced today a joint commercialization partnership with Astellas Pharma, Inc. of Tokyo, Japan focused on the delivery of personalized cancer therapeutics and diagnostics.
In other Medicaid news, Florida officials are trying to change the "Medically Needy" program and the Connecticut House passes a budget that would cut $50 million from Medicaid programs.
In RISING PLAGUE: THE GLOBAL THREAT FROM DEADLY BACTERIA AND OUR DWINDLING ARSENAL TO FIGHT THEM (Prometheus Books, $26), Dr. Brad Spellberg-an infectious diseases specialist and member of a national task force charged with attacking antibiotic resistant infections-tells the story of this potentially grave public health crisis.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Paul Thomas Lui, MD 2149 E Warner Rd Ste 102, Tempe, AZ 85284-3495 Ph: (480) 610-6100 | Paul Thomas Lui, MD 2121 N Beverly Ave, Ste 105, Tucson, AZ 85712-2154 Ph: (520) 327-6265 |
News Archive
Ever since discovering a decade ago that a gene altered in lung cancer regulated an enzyme used in therapies against diabetes, Reuben Shaw has wondered if drugs originally designed to treat metabolic diseases could also work against cancer.
Cell Signaling Technology, Inc. of Danvers, MA announced today a joint commercialization partnership with Astellas Pharma, Inc. of Tokyo, Japan focused on the delivery of personalized cancer therapeutics and diagnostics.
In other Medicaid news, Florida officials are trying to change the "Medically Needy" program and the Connecticut House passes a budget that would cut $50 million from Medicaid programs.
In RISING PLAGUE: THE GLOBAL THREAT FROM DEADLY BACTERIA AND OUR DWINDLING ARSENAL TO FIGHT THEM (Prometheus Books, $26), Dr. Brad Spellberg-an infectious diseases specialist and member of a national task force charged with attacking antibiotic resistant infections-tells the story of this potentially grave public health crisis.
› Verified 2 days ago
Dr. Basel Skeif, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5140 E Glenn St, Tucson, AZ 85712 Phone: 520-838-3540 Fax: 520-325-3526 | |
Dr. David Spencer Hamilton Sr., MD Nephrology Medicare: Medicare Enrolled Practice Location: 3601 S 6th Ave, Tucson, AZ 85723 Phone: 520-792-1450 | |
Diana Silva Cantillo, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1230 S Cherrybell Stra, Tucson, AZ 85713 Phone: 520-628-8287 | |
Basel Shoua, M.D Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2070 W Rudasill Rd Ste 130, Tucson, AZ 85704 Phone: 520-797-4468 Fax: 520-797-4502 | |
Hadil Owaynat, DO Nephrology Medicare: Medicare Enrolled Practice Location: 1501 N Campbell Ave Rm 6336, Tucson, AZ 85724 Phone: 520-626-2760 Fax: 520-626-6020 | |
Dr. David M Schwartz, DO Nephrology Medicare: Not Enrolled in Medicare Practice Location: 6200 N La Cholla Blvd, Tucson, AZ 85741 Phone: 520-469-8011 Fax: 520-469-8021 | |
Kenneth Alex Murachanian, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 6060 N Fountain Plaza Dr Ste 270, Tucson, AZ 85704 Phone: 520-229-2578 |